Credit Suisse Ag Ampio Pharmaceuticals, Inc. Transaction History

Credit Suisse Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.16 - $0.47 $1 - $4	9 New	9 $0
Q2 2021 Aug 16, 2021	SELL	$1.56 - $1.98 $27,824 - $35,315	-17,836 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$1.36 - $2.49 $24,256 - $44,411	17,836 New	17,836 $30,000
Q3 2019 Nov 12, 2019	SELL	$0.38 - $0.52 $10,528 - $14,407	-27,707 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$0.39 - $0.7 $1,843 - $3,308	4,727 Added 20.57%	27,707 $11,000
Q1 2019 May 14, 2019	BUY	$0.43 - $0.68 $2,749 - $4,348	6,395 Added 38.56%	22,980 $13,000
Q4 2018 Feb 13, 2019	BUY	$0.39 - $0.7 $6,468 - $11,609	16,585 New	16,585 $7,000
Q3 2018 Nov 13, 2018	SELL	$0.44 - $3.02 $10,167 - $69,786	-23,108 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$1.66 - $3.82 $38,359 - $88,272	23,108 New	23,108 $51,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.